These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18362668

  • 1. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.
    Hurmeric V, Mumcuoglu T, Erdurman C, Kurt B, Dagli O, Durukan AH.
    Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668
    [Abstract] [Full Text] [Related]

  • 2. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
    Hashemian MN, Moghimi S, Kiumehr S, Riazi M, Amoli FA.
    Ophthalmic Res; 2009 Apr; 42(2):90-5. PubMed ID: 19546599
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
    Papathanassiou M, Theodossiadis PG, Liarakos VS, Rouvas A, Giamarellos-Bourboulis EJ, Vergados IA.
    Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
    [Abstract] [Full Text] [Related]

  • 4. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.
    Öner V, Küçükerdönmez C, Akova YA, Çolak A, Karalezli A.
    Ophthalmic Res; 2012 Mar; 48(3):118-23. PubMed ID: 22538642
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Subconjunctival bevacizumab injection for corneal neovascularization.
    Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A.
    Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
    Kang S, Chung SK.
    Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
    [Abstract] [Full Text] [Related]

  • 14. The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency.
    Lin CT, Hu FR, Kuo KT, Chen YM, Chu HS, Lin YH, Chen WL.
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6277-85. PubMed ID: 20435600
    [Abstract] [Full Text] [Related]

  • 15. The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization.
    Habot-Wilner Z, Barequet IS, Ivanir Y, Moisseiev J, Rosner M.
    Acta Ophthalmol; 2010 Dec; 88(8):862-7. PubMed ID: 19549103
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization.
    Ozdemir O, Altintas O, Altintas L, Ozkan B, Akdag C, Yüksel N.
    Arq Bras Oftalmol; 2014 Aug; 77(4):209-13. PubMed ID: 25410169
    [Abstract] [Full Text] [Related]

  • 17. Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
    Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F.
    Clin Exp Ophthalmol; 2007 Nov; 35(8):745-8. PubMed ID: 17997779
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
    You IC, Kang IS, Lee SH, Yoon KC.
    Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The inhibitory effects of trastuzumab on corneal neovascularization.
    Güler M, Yilmaz T, Ozercan I, Elkiran T.
    Am J Ophthalmol; 2009 Apr; 147(4):703-708.e2. PubMed ID: 19054498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.